In Brief Indonesia, CRUK Scotland Institute partner to advance cancer research May 09, 2025Vol.51 No.18
Funding Opportunities CDMRP announces rare cancers research program funding opportunities for FY25 May 09, 2025Vol.51 No.18
Clinical Roundup Incidence rates of some cancer types have risen in people under age 50, NCI study shows May 09, 2025Vol.51 No.18
Clinical Roundup Durvalumab regimen demonstrates improvement in DFS for high-risk NMBIC in phase III trial May 09, 2025Vol.51 No.18
Clinical Roundup Zinc-transporting protein contributes to aggressive growth of brain tumor, study shows May 09, 2025Vol.51 No.18
Clinical Roundup Dxcover presents first real-world evidence that increased tumor size is associated with higher mortality in brain cancer May 09, 2025Vol.51 No.18
Drugs & Targets FDA grants accelerated approval to avutometinib + defactinib for KRAS-mutated recurrent LGSOC May 09, 2025Vol.51 No.18
Drugs & Targets EU approves Calquence + chemo as first and only BTK inhibitor for first-line MLC May 09, 2025Vol.51 No.18
Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors May 02, 2025Vol.51 No.17By Jacquelyn Cobb
